Binxian Wei
Independent DirectorMr. Binxian Wei, also known as Phil, serves as Independent Director of Palisade Bio, Inc. from February 05, 2019. He is a Director of Seneca Biopharma, Inc. (formerly known as Neuralstem, Inc.) since February 5, 2019. He has been the Vice President of Darsheng Trade & Tech. Development Co, Ltd. (a subsidiary to Tianjin Tiayo Pharmaceutical Co., Ltd.) since 2015. From 2008 through 2010, he worked as a business development manager for Sakai Trading. He holds a Master’s degree in Mathematical & Computer Sciences from Colorado School of Mines, a Master’s Degree and B.S. in Chemical Engineering from Tianjin University in China. He was appointed as the director representative of the Series A 4.5% Convertible Preferred Stock by Tianjin Pharmaceuticals Group International Holdings Co., LTD.
Positions
- Company NamePalisade Bio, Inc.Stock CodePALIPositionIndependent DirectorColleagues
- JDJ. D. FinleyCEO, CFO & Director
- DADonald A. WilliamsIndependent Chairman of the Board
- MLMitchell Lawrence JonesPresident & Chief Medical Officer
- RCRamesh C. DonthamsettyHead of IR and Corporate Strategy
- JEJulien E. CapersGeneral Counsel & Corporate Secretary
- JHJoerg HeyerHead of Translational Science & Medicine
- ECEmil ChuangIndependent Director
- BEBruce E. SandsMember of Clinical Advisory Board
